O

OmniAb Inc
NASDAQ:OABI

Watchlist Manager
OmniAb Inc
NASDAQ:OABI
Watchlist
Price: 1.91 USD 1.06% Market Closed
Market Cap: 275m USD

Wall Street
Price Targets

OABI Price Targets Summary
OmniAb Inc

Wall Street analysts forecast OABI stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for OABI is 7.48 USD with a low forecast of 3.03 USD and a high forecast of 11.55 USD.

Lowest
Price Target
3.03 USD
59% Upside
Average
Price Target
7.48 USD
292% Upside
Highest
Price Target
11.55 USD
505% Upside
OmniAb Inc Competitors:
Price Targets
CSBR
Champions Oncology Inc
81% Upside
DHR
Danaher Corp
10% Upside
MXCT
MaxCyte Inc
353% Upside
MTD
Mettler-Toledo International Inc
3% Upside
LAB
Standard BioTools Inc
3% Upside
688046
GemPharmatech Co Ltd
21% Upside
TKNO
Alpha Teknova Inc
119% Upside
DXRX
Diaceutics PLC
43% Upside

Revenue
Forecast

Revenue Estimate
OmniAb Inc

For the last 4 years the compound annual growth rate for OmniAb Inc's revenue is 3%. The projected CAGR for the next 4 years is 23%.

3%
Past Growth
23%
Estimated Growth
Estimates Accuracy
0%
Average Beat

Operating Income
Forecast

Operating Income Estimate
OmniAb Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Net Income
Forecast

Net Income Estimate
OmniAb Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-32%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is OABI's stock price target?
Price Target
7.48 USD

According to Wall Street analysts, the average 1-year price target for OABI is 7.48 USD with a low forecast of 3.03 USD and a high forecast of 11.55 USD.

What is OmniAb Inc's Revenue forecast?
Projected CAGR
23%

For the last 4 years the compound annual growth rate for OmniAb Inc's revenue is 3%. The projected CAGR for the next 4 years is 23%.

Back to Top